Settlement Reached In Drug Maker Case
Ohio's attorney general says the state's share of the settlement between Endo Health and the federal government amounts to about $5 million.
Federal prosecutors say the drug maker will pay almost $193 million to resolve claims that it improperly marketed the shingles treatment Lidoderm for unapproved uses, including treating lower back pain. The Pennsylvania company will pay nearly $172 million in civil false claims settlements largely to the federal government. Doctors can prescribe medicine for any use, but drug makers cannot promote them in ways the U.S. Food and Drug Administration has not approved.